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VanguardA cross-sectional study in two hospitals was performed on 807 patients with a primary Vanguard (Biomet)
total knee Arthroplasty (TKA). The research questions addressed were (1) what are the two- and six year
survival rates of the Vanguard, (2) what are the clinical outcome scores, (3) what are the ﬁndings at revision
and (4) what are predictors for revision? The mean age at time of surgery was 67.0 (SD 10.0). The mean
follow-up was 3.6 years (95% CI 3.56–3.73). At two years the survival was 97.2% for all-reasons (767 patients
remaining) and 99%, for prosthesis-related-reasons (777 remaining). At six years this was 96.5% (40
remaining) and 98.6% (41 remaining). The mean clinical results (84% response on KOOS, Oxford and NRS)
were good. A previous osteotomy was a risk factor for revision (hazard ratio 5.1, P = 0.001). This early
experience with the Vanguard shows a good survival with no adverse outcomes related to the implant and
therefore further use of the implant is justiﬁed.artment of orthopedics of the
grant for the employment of a
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14 Elsevier Inc. All rights reserved.© 2014 Elsevier Inc. All rights reserved.Total knee arthroplasty (TKA) is a highly effective treatment for
debilitating pain resulting from osteoarthritis of the knee [1]. The
Vanguard Complete Knee System (Biomet, Inc, Warsaw, Ind) is a
relatively new knee arthroplasty system that was introduced in
2003. Its design is a result of experience with the earlier AGC and
Maxim prostheses. However, to date the midterm survival and
patient reported outcome measures (PROMs) for this prosthesis
are unknown.
The revision rate of an implant is an important outcome measure
in evaluating survival of a new TKA design. To make survival data
comparable between different prostheses designs, revision is used as
a failure end-point. The rate of ‘Revisions per 100 observed
component years’ can then be calculated. According to a recent
study which combined the national databases of 6 different countries
there are 1.26 revisions per 100 observed component years [2]. This
number is the average revision rate for different knee designs in
multiple countries. Clinical studies are valuable in addition to registrydata as they can provide more details on the study population, the
procedure and other aspects of the outcome.
If the early survival rate would be known, and turns out to be good
in comparison with other prostheses, then this would justify further
use of the Vanguard TKA.
The primary research question was therefore what are the two-
and six-year survival rates of the Vanguard TKA. Secondary research
questions are what are the clinical outcome scores, what are ﬁndings
at the time of revision surgery and what are potential preoperative
and perioperative predictors for revision.
Materials and Methods
A retrospective cross-sectional study was performed. All
primary Vanguard total knee arthroplasties of two hospitals
involved in the same residential program were included. In the
Academic Medical Center, a university medical center, the prosthesis
was introduced in April 2007 and in the Amphia Hospital in June 2005.
For all patients the indication for surgery was based on patient history
and physical examination combined with anteroposterior and lateral
radiography. Both posterior stabilized (PS) and cruciate retaining (CR)
prostheseswere implanted. Only patients operated at least 2 years prior
to February 2012 were included in this study.
For all patients follow-up, age at operation, indication for surgery,
revision and revision date, complications, the presence of rheumatoid
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time, type of anesthesia, pre-operative hemoglobin as well as 1- and 3-
day post-operative hemoglobin and admittance periodwere registered.
If patients were still alive at follow-up they were invited to ﬁll out
two questionnaires and a pain score as described below.
Operative Technique and Rehabilitation
The operative technique was in accordance with the surgical
technique guide provided by Biomet. Surgery was performed or
supervised by an experienced orthopedic surgeon. Pre-operative
antibiotics were given thirty minutes before incision. Patients started
withmobilization on the day after surgery dependent on pain. Normal
expectancy was unaided walking after 6 weeks of rehabilitation. The
mean Hospital stay was 5 days. In the questionnaires patients are
asked if they had received a revision operation in any other hospital.
Clinical Outcome on KOOS, Oxford and NRS
The Knee injury Osteoarthritis Outcome Score (KOOS [3]) question-
naire, an Oxford[4] questionnaire and an 11-point Numeric Rating Scale
(NRS) for pain ranging from0 to 10were used at follow-up. The KOOS is
a 42 item site speciﬁc questionnaire, resulting in ﬁve 0–100 scores
(higher is better) for Pain, Symptoms, activities of daily life (ADL), Sport
& Recreation and quality of life (QOL). The Oxford is a 12 item site
speciﬁc score, ranging from 0 to 48 (higher is better). For a proper
comparison with the Swedish Knee Arthroplasty Register (SKAR) [5],
the results are presented as means with 95% conﬁdence intervals.
Findings During Revision
All operative reports of the revised patients were reviewed and
intra-operative ﬁndings were noted.
Risk Factors for Revision
Predictors for revision that were analyzed were based on the SKAR
[5]. Age at operation, BMI, ASA classiﬁcation, implantation in the ﬁrstTable 1
Demographics at Index Operation.
Age (years) mean (SD)
BMI (kg/m2) mean (SD)
Follow-up mean (SD)
Hospitalization period in days median (range)
Pre-op hemoglobin, mean (SD)
Post-op hemoglobin day 1, mean (SD)








Smoking at operation No
Yes
Diabetes at operation No
Yes
Reumatoid arthritis at operation No
Yes
Osteotomy before operation No
Yes
Type prothesis — Cruciate retaining (CR) vs posterior stabilized (PS) CR
PS
Anaesthesia used General
Spinalyear of the introduction of the prosthesis in either clinic (learning
curve issues), gender, rheumatoid arthritis and post-osteotomy
osteoarthritis were evaluated.
Statistical Analysis
For statistical analysis SPSS 20.0 (IBM SPSS Statistics) was
used to calculate survival rate of the knee arthroplasty according
to the method of Kaplan–Meier (observed cumulative survival).
The end point was deﬁned as the addition or change of one or
more components of the prosthesis. Separate analyses were
performed for the endpoints “revision for prosthesis related
reasons” (RPR) as well as “revision for all reasons” (RAR). RPR
was deﬁned as revision for mechanical aseptic loosening, wear of
one or more parts of the implant, breakage or instability due to
implant failure that required surgical arthroplasty of one or more
components. RAR is deﬁned as all the above reasons with the
addition of septic loosening, revision for malpositioning of the
prosthesis or patellofemoral knee pain requiring a patella
prosthesis placement. Deaths without revision were treated as
censored data (with censoring the date of death). The survival
curves were plotted using R statistics (The Comprehensive R
Archive Network).
The risk factors for revision were entered as covariate factors in a
Cox proportional hazards model using backward LR method to
determine whether the risk of requiring revision surgery was related
to these factors.
The null hypothesis was that these covariate factors were not
related to revision. Hazard ratios (HR) and corresponding 95%
conﬁdence intervals (CI) were reported. For categorical variables in
the model (ASA, ﬁrst year, gender, rheumatoid arthritis and post-
osteotomy osteoarthritis) one category was deﬁned as a reference
having the relative risk of 1.0, to which the other categories were
then compared. For numerical variables (age at operation and BMI),
the risk ratio is related to the change in risk if the variable increases
by one unit. To determine the Odds Ratio (OR) of revision surgery
for speciﬁc risk factors a multivariate logistic regression analysis
was performed.All n = 807 Male n = 289 (35.8%) Female n = 518 (64.2%)
67.0 (10.0) 65.0 (10.1) 68.0 (9.8)
29.4 (4.8) 28.6 (4.4) 29.9 (4.9)
3.6 (1.3) 3.6 (1.3) 3.6 (1.2)
6 (1–38) 6 (2–38) 6 (1–37)
8.6 (0.8) 9.1 (0.8) 8.4 (0.7)
7.2 (0.8) 7.5 (0.9) 7.0 (0.7)
6.5 (0.9) 6.7 (0.9) 6.4 (0.8)
N (%) N (%) N (%)
273 (33.9) 115 (39.8) 158 (30.6)
310 (38.5) 108 (37.4) 202 (39.1)
223 (27.7) 66 (22.8) 157 (30.4)
144 (18.5) 62 (22.5) 82 (16.3)
457 (58.7) 150 (54.5) 307 (60.9)
175 (22.5) 60 (21.8) 115 (22.8)
3 (0.4) 3 (1.1) 0 (0)
681 (84.4) 229 (79.2) 452 (87.3)
126 (15.6) 60 (20.8) 66 (12.7)
698 (86.5) 252 (87.2) 446 (86.1)
109 (13.5) 37 (12.8) 72 (13.9)
769 (95.3) 275 (95.2) 494 (95.4)
38 (4.7) 14 (4.8) 24 (4.6)
771 (95.5) 267 (92.4) 504 (97.3)
36 (4.5) 22 (7.6) 14 (2.7)
383 (48.7) 141 (50.4) 242 (47.7)
404 (51.3) 139 (49.6) 265 (52.3)
397 (50.8) 141 (51.1) 256 (50.7)
384 (49.2) 135 (48.9) 249 (49.3)
Fig. 1. Kaplan–Meier survival function with 95% conﬁdence intervals for prosthesis related reasons and for all reasons.
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demographic data and baseline characteristics. Normally distributed
data, as tested with the Shapiro/Wilk test and additional visual
inspection, were reported by mean and 95% conﬁdence interval (CI).
Not-normally distributed data were reported by median and range.
For normally distributed variables the unpaired t-tests were
performed, Mann–Whitney tests were used for continuous non-
normally distributed variables and chi-square tests for dichotomous
variables to verify homogeneity between groups. For the casemix
table, means and 95% CI were presented so data would be
comparable to SKAR. A P value smaller than 0.05 was considered
statistically signiﬁcant.Fig. 2. Flow-chart forResults
Between June 2005 and 15 February 2010, 807 patients, 289male and
518 female,with amean age of 67.0 (SD10.0; range 37.8–93.1) received a
primaryVanguard total knee arthroplasty in theAcademicMedical Center
Amsterdamand theAmphiaHospital inBreda (Table1). Themean follow-
up was 3.6 years (95% CI 3.56–3.73) ranging from two to seven years.
Survival Analysis
The RPR survival rate was 99% (95% CI: 98.2–99.8) at 2 years with
777 patients remaining, 98.6% (95% CI: 97.8–99.4) at 6 years with 41patient inclusion.
Table 2
Casemix Data of Study Group.
Pain Symptom ADL Sport & Recreation QOL Total Oxford Score NRS for Pain
Count Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI)
Total 807 76.8 (74.9–78.8) 73.2 (71.5–74.8) 73.5 (71.5–75.5) 38.3 (35.5–41.1) 60.0 (57.7–62.3) 36.3 (35.5–37.2) 2.5 (2.3–2.7)
Gender
Male 289 80.8 (77.9–83.7) 75.1 (72.3–77.9) 78.0 (74.9–81.0) 44.7 (40.1–49.2) 62.7 (59.0–66.5) 38.3 (37.0–39.6) 2.1 (1.8–2.5)
Female 518 74.5 (72.0–77.1) 72.0 (70.0–74.0) 70.9 (68.3–73.5) 34.5 (31.0–38.0) 58.5 (55.6–61.3) 35.2 (34.1–36.2) 2.7 (2.4–3.0)
Age group at operation
b55 98 76.4 (70.3–82.6) 67.7 (62.8–72.5) 73.9 (67.8–79.9) 42.1 (34.0–50.1) 56.8 (50.7–62.9) 35.6 (33.1–38.1) 2.6 (2.0–3.3)
55–65 256 78.2 (75.0–81.4) 72.5 (69.6–75.3) 76.0 (72.8–79.2) 39.3 (34.9–43.8) 60.7 (56.9–64.5) 37.1 (35.7–38.6) 2.4 (2.1–2.8)
65–75 253 76.9 (73.5–8.4) 74.5 (71.7–77.2) 74.6 (71.2–78.1) 39.1 (34.3–44.0) 60.7 (56.7–64.8) 36.8 (35.4–38.1) 2.4 (2.0–2.9)
75–85 190 73.4 (69.1–77.7) 74.6 (71.1–78.1) 65.5 (60.8–70.2) 29.1 (22.1–36.1) 58.2 (52.7–63.7) 34.5 (32.5–36.4) 2.8 (2.2–3.3)
N85 10 93.9 (81.9–105.9) 94.7 (88.9–100.5) 90.9 (73.0–108.8) 80.0 (44.0–116.0) 90.0 (70.4–109.6) 37.4 (27.4–47.5) 0.8 (−0.6–2.2)
BMI group at operation
Healthy 131 82.5 (78.4–86.6) 77.1 (73.2–80.9) 81.2 (77.5–85.0) 42.9 (42.9–36.8) 65.8 (60.7–70.9) 39.1 (37.4–40.8) 2.1 (1.6–2.6)
Overweight 327 77.1 (74.1–80.1) 73.4 (70.9–75.8) 73.5 (70.4–76.6) 37.0 (32.8–41.2) 59.9 (56.4–63.4) 36.8 (35.6–38.1) 2.4 (2.0–2.7)
Obese 290 74.7 (71.3–78.1) 70.7 (67.9–73.6) 70.8 (67.3–74.3) 37.5 (32.6–42.4) 58.1 (54.2–62.0) 34.8 (33.3–36.3) 2.7 (2.3–3.1)
Morbidly obese 19 66.7 (51.2–82.1) 77.3 (69.0–85.6) 61.4 (44.4–78.3) 48.5 (23.0–74.0) 48.9 (33.7–64.0) 32.5 (25.4–39.5) 3.9 (1.4–6.4)
ASA
1 & 2 601 77.8 (75.6–80.0) 73.5 (71.7–75.4) 75.6 (73.4–77.9) 39.9 (36.8–43.1) 61.1 (58.5–63.7) 37.1 (36.2–38.0) 2.4 (2.1–2.6)
3 & 4 178 74.5 (70.2–78.9) 72.7 (69.2–76.3) 66.8 (62.1–71.6) 33.6 (26.8–40.4) 56.3 (51.1–61.5) 33.6 (31.7–35.6) 3.0 (2.4–3.5)
Year of surgery
2005 27 71.4 (60.7–82.1) 72.9 (63.9–81.9) 72.9 (61.9–83.8) 32.1 (19.6–44.6) 59.4 (47.1–71.7) 33.4 (27.7–39.0) 3.6 (2.0–5.1)
2006 62 78.4 (71.7–85.1) 72.6 (66.7–78.4) 75.0 (67.8–82.1) 36.0 (26.8–45.3) 60.2 (52.2–68.2) 37.4 (34.3–40.5) 2.3 (1.5–3.2)
2007 186 74.3 (69.7–78.9) 72.8 (69.4–76.3) 71.4 (66.7–76.1) 40.1 (33.7–46.6) 59.3 (53.8–64.7) 35.7 (33.7–37.8) 2.5 (2.0–3.0)
2008 155 73.5 (68.7–78.4) 72.0 (68.2–75.7) 71.4 (66.7–76.2) 35.9 (29.7–42.2) 59.4 (54.1–64.7) 35.0 (33.1–36.9) 2.5 (2.0–3.0)
2009 329 79.5 (76.6–82.3) 74.4 (71.9–77.0) 75.0 (72.0–78.0) 38.9 (34.5–43.2) 61.2 (57.8–64.7) 37.0 (35.8–38.3) 2.4 (2.0–2.7)
2010–February 48 79.1 (72.8–85.3) 70.5 (64.2–76.8) 75.7 (69.5–81.9) 41.5 (30.8–52.1) 56.9 (48.9–64.9) 37.9 (35.3–40.5) 2.7 (1.8–3.5)
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2 years with 767 patients remaining, 96.5% (95% CI: 95.1–97.9) at
6 years with 40 patients remaining (Fig. 1).
Expressed in revisions per 100 prosthesis years, RPR was 0.38/
100 years and RAR was 0.94/100 years.
Clinical Outcome on KOOS, Oxford and NRS
Of the 807 patients identiﬁed as having received a primary
Vanguard total knee arthroplasty 43 (5%) had died at follow-up. This
left 764 patients to be invited to participate in the questionnaire
follow-up, of which 640 responded (84%). Of these responders, 78 didFig. 3. Kaplan–Meier survival function with 95% conﬁdence intervals fornot want to participate (Fig. 2). None of these patients had undergone
revision surgery. The means of the clinical results as measured with
the KOOS were Pain 76.8 (95% CI: 74.9–78.8), Symptoms 73.2 (95% CI:
71.5–74.8), ADL 73.5 (95% CI: 71.5–75.5), Sport & Recreation 38.3
(95% CI: 35.5–41.1) and QOL 60.0 (95% CI: 57.7–62.3). The mean
Oxford score was 36.3 (95% CI: 35.5–37.2) and NRS 2.5 (95% CI: 2.3–
2.7) (Table 2).
Findings During Revision
RPR was performed in 11 patients. Six of these 11 patients had
aseptic loosening of the tibial component of whom 1 patient alsopatients who had undergone osteotomy and patients who had not.
Fig. 4. Difference in survival probability with 95 % conﬁdence intervals between patients who had undergone osteotomy and patients who had not.
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the prosthesis–cement interface failed and in one patient the bone–
cement interface failed. Four of these 11 patients had aseptic
loosening of both the femoral and the tibial component of whom
one patient also required a patellar component. One of these 11
patients had femoral loosening and required a patellar component. All
the loosened components had been cemented at initial operation. All
the loosened components were revised while the ﬁxed components
were left in situ.
RAR was performed in an additional 16 patients. Fourteen patellar
prostheses were added for treating the patellofemoral pain. Two
femoral revisions were performed for malpositioning. One 2-stage
revision was performed for septic loosening. One femoral component
exchange, from CR to PS, was performed for persistent post-traumatic
instability due to posterior cruciate ligament insufﬁciency.
Risk Factors for Revision
The multivariate logistic regression analysis showed that an
osteotomy prior to the TKA increased the risk of RAR (odds ratio
(OR) 6.9, P b 0.001) in a model with age, BMI, ASA classiﬁcation, ﬁrst
year of implantation, gender and rheumatoid arthritis. A prior
osteotomy increases the risk for an early revision (hazard ratio (HR)
5.1, P value = 0.001) (Figs. 3 and 4). All revisions had a previous open
wedge HTO but there was insufﬁcient detail in the operative reportsTable 3
Outcome Scores for No Osteotomy and Osteotomy Patients.
No Osteotomy
Median (Range) Count
Pain 86 (0–100) 528
Symptom 75 (11–100) 532
ADL 80 (0–100) 528
Sport & Recreation 33 (0–100) 493
QOL 63 (0–100) 524
Total Oxford score 40 (0–48) 535
NRS for pain 1 (0–10) 496
a Mann–Whitney test.to report the speciﬁc technique used. After ﬁnding this risk factor for
revision an analysis was performed to test for differences in clinical
outcome scores for these two patient groups but no statistically
signiﬁcant differences were found (Table 3).
Discussion
The RAR survival was 97.2% at 2 years with 767 patients
remaining, 96.5% at 6 years with 40 patients remaining. A recent
study on the long term survival results of the AGC reported a
comparable 98% survival at two years and 95% at six years for all
reasons [6]. The RPR survival was 99% at 2 years with 777 patients
remaining, 98.6% at 6 years with 41 patients remaining. Expressed in
revisions per 100 prosthesis years, RPR was 0.38/100 years and RAR
was 0.94/100 years.
These results can be considered better than average with 6%
revision after 5 years and 1.26/100 years being the expected value as
calculated from 6 national implant registers [2].
The patient reported outcome measures (PROMs) are comparably
good when compared to previous reports using the same PROMs
(Fig. 5) [5,7,8]. A difference is considered clinically relevant when it is
more than 10 points on the KOOS as well as on the 0–100 VAS [5,7]. To
compare the mean VAS of previous studies with the mean NRS of the
current study, the NRS score was multiplied by ten. For this
comparison it should be considered that NRS scores are generallyOsteotomy
Median (Range) Count P Valuea
80 (6–94) 25 .518
79 (29–71) 25 .891
78 (0–100) 25 .657
25 (0–100) 25 .597
50 (0–100) 25 .301
39 (7–48) 24 .548
3 (0–9) 23 .081
Fig. 5. Patient reported outcome measures, KOOS (0–100, higher better), Oxford (0–48, higher better) and NRS/VAS (0–100, lower better), compared to results of previous studies
with 95% CI (SKAR = Swedish Knee Arthroplasty Registry; n/a = not available; * = maximum Oxford-score).
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clinically relevant differences between the studies. The Vanguard in
the current study seems to perform equally well on PROMs as
compared to the AGC-studies and the SKAR.
Themain revision issue in the short-term follow-up periodwas the
addition of a patellar prosthesis at follow-up with 17 (2%) patellar
prostheses being added. In a recent meta-analysis it was reported that
48 (6%) of 792 knees in the non-resurfacing group had further
procedures because of anterior knee pain [9]. In this meta-analysis it
was reported that follow-up of the randomized controlled trials was
short, with the latest follow-up often being ﬁve years of the index
procedure. As in this study the percentage was lower (2%), it was
assumed that these revisions were to be expected based on natural
progression of patellofemoral arthritis rather than being due to, for
example, trochlear groove design.
One of the ﬁndings of this study is that a prior osteotomy
signiﬁcantly increases the chance of needing a RAR during follow-up.
The rate of revision after osteotomy was 4.01 revisions/100 prosthesis
years at 3.46 years. There were ﬁve revisions in 36 patients, three
patellar additions for patellofemoral pain and two component changes.
All these patients had undergone an open wedge high tibial osteotomy.
Several studies have reported on previous osteotomy in relation to the
revision rate of TKA among which two large studies [10,11]. For the
purpose of comparison, the revision rates per 100 prosthesis years
were calculated. This resulted in respectively 1.33 [11] and 2.70 [10]
revisions/100 prosthesis years for these studies at 4.7 and 5.0 years of
follow-up. Hence, the TKA revisions rates after a prior osteotomy are
higher than the average 1.26 revisions/100 years reported for a normal
TKA. The reason for this might be the changed geometry of the knee
joint. High tibial osteotomy can result in patella baja or patella alta
depending on the choice of a closewedge or an openwedge osteotomy.A case could be made that in these patients a patellar component
should always be implanted due to changes in the geometry and the
risk of patellar maltracking. Furthermore due to a potential asymmetric
tibial cut during TKA placement a more than average ligamentous
misbalance in need of more releases and balancing can arise [12]. It has
been reported that TKA after high tibial osteotomy can lead to
increased loosening and lysis during follow-up [12]. Some studies
have reported similar outcome scores for patients following HTO [13–
15] while others have reported inferior results [12,16–18]. In this study
no differences in outcome scores were found between these two
groups but this was after some patients had been reoperated and the
cause of the pain had been treated. It must be taken into account that
HTO can postpone the need for TKA by many years so it should not be
concluded that HTO should no longer be performed. It is however
important to realize that these patients need to be informed about a
higher revision rate if they need a TKA, even after years of successful
outcome following HTO. Signiﬁcant differences in HTO technique can
play a role in outcome for the index operation and revision to TKA. In
this study detailed information on different techniques could not be
identiﬁed, although it was known that all HTO procedures had been
open wedge procedures. Future research should focus on the outcome
of TKA following different HTO techniques.
The study design was retrospective in nature with prospectively
recorded surgical and clinical details. With the number of events
being low, one could argue that the study was underpowered to
adequately prove statistically signiﬁcant risk factors for revision.
Nonetheless, a prior osteotomy was a statistically signiﬁcant factor. It
must be mentioned however that the lack of more detailed
information on the different HTO techniques used is a limitation.
Furthermore, there is a chance that patients have undergone a
revision operation in another hospital. In this study the patients were
354 A.J. Kievit et al. / The Journal of Arthroplasty 29 (2014) 348–354asked for re-operations performed in another hospital. Two patients
answered that this was indeed the case. It was unclear however if this
had been a revision operation or a reoperation for any other reasons as
patients gave no clear details. Themethod of calculating ‘Revisions per
100 observed component years’ has a downside in that it does not
take into account that prosthesis survival curves are not linear. As a
result, at midterm follow-up the revision rate will be relatively high
compared to for instance at 10 year follow-up, as most revisions
within this period occur in the ﬁrst few years.
The current study was performed in two centers, one university
hospital and one general hospital, in different parts of the Nether-
lands. This resulted in a heterogeneous patient populationmaking the
results more externally valid, at least for the Netherlands. In one
hospital on average 120 and in the other 500 TKAs are performed
annually. The response rate was high which resulted in an adequate
representation of the patient population. The database was extensive
in detail for pre-operative demographics. All patients who received a
primary Vanguard were included and a good sample size was
achieved for the survival analysis.
The patient group will be followed until long-term follow-up
analysis can be performed to check if this new design continues to
perform equally well or better than previous designs.
Conclusion
This early experience with the Vanguard shows a good survival
with no adverse outcomes related to the implant and therefore further
use of the implant is justiﬁed. The main reason for revision is
patellofemoral pain. Patients who have undergone a prior osteotomy
have aﬁvefold higher chanceof revision compared to patientswithout.
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